iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance.
Latest Ratings for IRTC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Morgan Stanley | Maintains | Overweight | |
| Feb 2022 | Needham | Upgrades | Hold | Buy |
| Jan 2022 | JP Morgan | Maintains | Overweight |
